Michelle de la Vega
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, RNA modifications and cancer, Cancer, Hypoxia, and Metabolism, Cell death mechanisms and regulation, Muscle Physiology and Disorders
Most-Cited Works
- → The Deubiquitinating Enzyme USP17 Is Highly Expressed in Tumor Biopsies, Is Cell Cycle Regulated, and Is Required for G1-S Progression(2010)111 cited
- → Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion(2011)103 cited
- → USP17 Regulates Ras Activation and Cell Proliferation by Blocking RCE1 Activity(2009)75 cited
- → The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility(2011)64 cited
- → Mutations in PTRH2 cause novel infantile‐onset multisystem disease with intellectual disability, microcephaly, progressive ataxia, and muscle weakness(2014)37 cited
- → The Deubiquitinating Enzyme USP17 Blocks N-Ras Membrane Trafficking and Activation but Leaves K-Ras Unaffected(2010)33 cited
- → Ubiquitination(2011)30 cited
- → Bit-1 is an essential regulator of myogenic differentiation(2015)18 cited
- → PTRH2 gene mutation causes progressive congenital skeletal muscle pathology(2017)15 cited
- → A novel RCE1 isoform is required for H-Ras plasma membrane localization and is regulated by USP17(2013)14 cited